These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


497 related items for PubMed ID: 24805974

  • 21. Detection of hepatitis B virus infection in German blood donors 2008-2015.
    Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M.
    Vox Sang; 2020 Apr; 115(3):152-161. PubMed ID: 32023664
    [Abstract] [Full Text] [Related]

  • 22. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P.
    Swiss Med Wkly; 2008 Mar 08; 138(9-10):134-41. PubMed ID: 18330733
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC, Busch MP.
    Mol Diagn Ther; 2006 Mar 08; 10(2):77-91. PubMed ID: 16669606
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Blood Transfus; 2017 Jan 08; 15(1):6-12. PubMed ID: 27416568
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P.
    Indian J Med Res; 2010 Sep 08; 132():312-7. PubMed ID: 20847378
    [Abstract] [Full Text] [Related]

  • 29. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z, Milani S, Sharifi Z.
    Arch Iran Med; 2014 Feb 08; 17(2):106-7. PubMed ID: 24527970
    [Abstract] [Full Text] [Related]

  • 30. Serological characterization of occult hepatitis B virus infection among blood donors in India.
    Doda V, Arora S, Kirtania T.
    Transfus Apher Sci; 2014 Oct 08; 51(2):162-7. PubMed ID: 25131822
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 08; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 34. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, Bock CT, Kremsner PG, Velavan TP.
    PLoS One; 2015 Jan 08; 10(7):e0131912. PubMed ID: 26148052
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
    Seo DH, Whang DH, Song EY, Kim HS, Park Q.
    Transfusion; 2011 Aug 08; 51(8):1840-6. PubMed ID: 21332731
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.
    Transfusion; 2018 Sep 08; 58(9):2166-2170. PubMed ID: 30144082
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
    Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M.
    Virol J; 2016 Mar 05; 13():36. PubMed ID: 26944046
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.